---
title: Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone
  for the treatment of people with high-risk newly diagnosed multiple myeloma
date: '2024-09-30'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39345094/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240930184655&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: No ...
disable_comments: true
---
No ...